Clinical Study
Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
Table 1
Tumor stage (clinical and surgical) distributions of the complete series.
(a) FIGO stage (clinical) |
| IA | 1 388 | IB | 865 | II | 185 | III | 108 | IV | 97 | None | 1 900 |
| Total | 4 543 |
|
|
1 840 patients were staged both clinically and surgically.
|
(b) FIGO stage (surgical) |
| I* | 899 | IA | 91 | IB | 1 453 | IC | 625 | II* | 130 | IIA | 50 | IIB | 100 | III* | 82 | IIIA | 84 | IIIB | 11 | IIIC | 68 | IVA | 3 | IVB | 144 | None | 803 |
| Total | 4543 |
|
|
*No further substage.
|